Association between Carotid Intima-Media Thickness and the Use of Biological or Small Molecule Therapies in Patients with Rheumatoid Arthritis.

Marta Rojas-Gimenez Clementina López MedinaJerusalem Calvo-GutiérrezMaría Ángeles Puche-Larrubia Ignacio Gómez-GarcíaPedro Seguí-AzpilcuetaMaría Del Carmen Ábalos-Aguilera Desirée Ruíz Eduardo Collantes-Estevez Alejandro Escudero-Contreras

Published in: Diagnostics (Basel, Switzerland) (2021)

The use of TNFα inhibitors may protect against subclinical atherosclerosis in patients with RA, patients on this biologic having smaller CIMTs than patients on other disease-modifying antirheumatic drugs. Nonetheless, these results should be confirmed in prospective studies with larger sample sizes.

Keyphrases

rheumatoid arthritis
small molecule
ejection fraction
end stage renal disease
newly diagnosed
prognostic factors
cardiovascular disease
metabolic syndrome
patient reported outcomes
systemic lupus erythematosus
interstitial lung disease